scholarly journals Hormone-Negative, Her2-Positive Male Breast Cancer with a Poor Prognosis: A Case Report

2019 ◽  
Vol 3 (1) ◽  
Author(s):  
Kitada Masahiro ◽  
Yasuda Shunsuke ◽  
Abe Masahiro ◽  
Yoshida Nana ◽  
Okazaki Satoshi ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Case Report ◽  
Male Breast Cancer ◽  
Poor Prognosis ◽  
Male Breast ◽  
Her2 Positive

Radiologic Findings of Male Breast Cancer: A Case Report

1994 ◽  
Vol 31 (4) ◽  
pp. 759
Author(s):  
Kyung Joo Park ◽  
Chun Hwan Han ◽  
Jeong Geun Yi ◽  
Joo Hyuk Lee
Keyword(s):  
Breast Cancer ◽  
Case Report ◽  
Male Breast Cancer ◽  
Male Breast ◽  
Radiologic Findings

scholarly journals A Case Report of Advanced Male Breast Cancer in A 70 Years Old Patient

2018 ◽  
Vol 26 ◽  
pp. 103-105
Author(s):  
Ashim K Ghosh ◽  
MM Arif Hosen ◽  
Julekha Khatun ◽  
Hasnina Akhter ◽  
F Farjana Shimu ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Case Report ◽  
Natural History ◽  
Male Breast Cancer ◽  
Male Breast ◽  
Significant Fraction

Male breast cancer is rare. It accounts for 0.2% of all cancers and about 1% of all breast cancer. Because of the rarity of the disease and the low index of suspension, diagnosis is delayed in a significant fraction of patients. The objective of this article is to increase the medical community's awareness of the disease in this setting and thus favorably change its natural history by earlier diagnosis. The present study reported the case of a 70 year old man who was diagnosed with an advanced infiltrating ductal carcinoma.TAJ 2013; 26: 103-105

scholarly journals Axillary metastasis as the first manifestation of male breast cancer: a case report

Cases Journal ◽  
2008 ◽  
Vol 1 (1) ◽  
Author(s):  
Guo-Li Gu ◽  
Shi-Lin Wang ◽  
Xue-Ming Wei ◽  
Li Ren ◽  
Fu-Xian Zou
Keyword(s):  
Breast Cancer ◽  
Case Report ◽  
Male Breast Cancer ◽  
Male Breast ◽  
Axillary Metastasis

Prolonged benefit from palbociclib plus letrozole in heavily pretreated advanced male breast cancer: case report and literature overview

2020 ◽  
pp. 030089162097698
Author(s):  
Emma Zattarin ◽  
Francesca Ligorio ◽  
Federico Nichetti ◽  
Giulia Bianchi ◽  
Giuseppe Capri ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Clinical Trials ◽  
Case Report ◽  
Male Breast Cancer ◽  
Clinical Case ◽  
Previous Treatment ◽  
Male Breast ◽  
Cancer Case ◽  
Heavily Pretreated ◽  
Breast Cancer In Men

Introduction: Breast cancer in men is less common than in women and treatment recommendations are often derived from clinical trials exclusively involving women. Data on efficacy of CDK 4/6 inhibitors, which are the mainstay of treatment for hormone receptor–positive/HER2-negative advanced breast cancer, are lacking in male patients. Case report: We present a clinical case of prolonged benefit from palbociclib in combination with letrozole and LHRH analogue in a man who had previously been treated with six lines of endocrine therapies and chemotherapy regimens but was still in excellent clinical condition. Conclusions: This clinical case demonstrates that male breast cancer stands out as an endocrine-sensitive disease, which could potentially benefit from CDK 4/6 inhibitors in combination with endocrine agents even in very heavily pretreated settings of disease, underscoring both the importance of an accurate selection of patients for later treatment lines, taking into account disease history and previous treatment responses, and the peculiarity of breast cancer in men, which deserves dedicated clinical trials to tailor future recommendations.

Male breast cancer in World War II aviation: a case report and review

The Breast ◽  
2003 ◽  
Vol 12 (2) ◽  
pp. 156-157 ◽  
Author(s):  
D.J Gordon ◽  
K.H Chin ◽  
P.G Budny ◽  
A.R Taylor
Keyword(s):  
Breast Cancer ◽  
World War Ii ◽  
Case Report ◽  
Male Breast Cancer ◽  
Male Breast ◽  
World War
Sign in / Sign up

Export Citation Format

Share Document